9D6C

QNG: Lenacapavir

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6V2F_QNG_C_300	100%	32%	0.032	0.993	1.39	1.31	6	8	0	0	100%	1
6VKV_QNG_A_301	68%	3%	0.114	0.925	2.59	3.6	20	20	1	0	100%	0.38
7RJ2_QNG_C_301	41%	3%	0.124	0.838	2.57	3.58	22	24	1	0	100%	0.5
7RJ4_QNG_C_301	40%	3%	0.11	0.818	2.6	3.65	22	18	3	0	100%	1
7RHN_QNG_C_301	9%	2%	0.197	0.678	2.7	3.69	20	22	0	0	100%	0.5

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.